RE:Next Quarter..
The next financials should give a diffinitive direction for sure. They will show a little growth from the Netherlands pilot but don't be surprised with the lack of revenue. SP really won't begin to really move until revenue can support all the claims that Mike has made to date. Losing the big pharmacy deal here was definitely a punch In the gut for Mike. Let's hope he recovers and demonstrates that Medx could be a leader in this space What I am still at a loss of understanding is why mdx has not partnered with Any dermalogical associations and marketed their product on any of their sites Like Melonoma Canada.